EGFR/TGFα and TGFβ/CTGF Signaling in Neuroendocrine Neoplasia: Theoretical Therapeutic Targets

Publisher： Karger

E-ISSN： 1423-0194|97|1|35-44

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.97, Iss.1, 2012-06, pp. : 35-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Signaling Pathways as Specific Pharmacologic Targets for Neuroendocrine Tumor Therapy: RET, PI3K, MEK, Growth Factors, and Notch

By  

Neuroendocrinology, Vol. 97, Iss. 1, 2012-02 ,pp. : 57-66

Karger

Access to resources Recommend Favorite

Rap1/B-Raf Signaling Is Activated in Neuroendocrine Tumors of the Digestive Tract and Raf Kinase Inhibition Constitutes a Putative Therapeutic Target

By  

Neuroendocrinology, Vol. 85, Iss. 1, 2007-03 ,pp. : 45-53

Karger

Access to resources Recommend Favorite

Angiogenesis in Neuroendocrine Tumors: Therapeutic Applications

By  

Neuroendocrinology, Vol. 97, Iss. 1, 2012-04 ,pp. : 45-56

Karger

Access to resources Recommend Favorite

Bronchopulmonary Neuroendocrine Neoplasms and Their Precursor Lesions in Multiple Endocrine Neoplasia Type 1

By  

Neuroendocrinology, Vol. 103, Iss. 3-4, 2015-06 ,pp. : 240-247

Karger

Access to resources Recommend Favorite

From Targets to Treatments: A Review of Molecular Targets in Pancreatic Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 94, Iss. 3, 2011-08 ,pp. : 177-190

Karger

Access to resources Recommend Favorite